Nvidia has added another key player! UBS Group: Raised target price to $150.
US stocks surge | Nvidia (NVDA.US) rises more than 2.7%, with UBS Group reiterating its "buy" rating.
Benzinga Market Summary: UBS Raises NVIDIA Price Target, Biden Commits To Staying In The Race, Boeing Strikes Plea Deal With DOJ
Wells Fargo Maintains Overweight on Meta Platforms, Raises Price Target to $625
Wells Fargo Maintains Equal-Weight on Alphabet, Raises Price Target to $187
UBS Maintains Buy on NVIDIA, Raises Price Target to $150
UBS Adjusts Price Target on NVIDIA to $150 From $120, Maintains Buy Rating
Wade Bush: Raises Meta's target price to $570.
Wedbush Adjusts Price Target on Meta Platforms to $570 From $480, Maintains Outperform Rating
Wells Fargo Adjusts Price Target on Alphabet to $187 From $168, Keeps Equalweight Rating
Barclays Remains a Buy on Eli Lilly & Co (LLY)
Raymond James Financial raised Nvidia's target price to $120.
Melius Research raised their target price for Apple to $260.
Raymond James Financial raised the target price of Microsoft to $480.
Eli Lilly and Co Analyst Ratings
Morgan Stanley Maintains Overweight on Eli Lilly and Co, Maintains $1023 Price Target
NVIDIA Analyst Ratings
Goldman Sachs raised the target price of Eli Lilly and Co. to $793.
Daheng Rating | Nomura: Reaffirming the target price of $240 for Amazon AWS is accelerating its development.
BMO Capital Maintains Outperform on Eli Lilly and Co, Maintains $1001 Price Target